CARsgen Therapeutics Holdings Limited (2171.HK) HKSE

16.06

-0.29(-1.77%)

Updated at January 14 04:08PM

Currency In HKD

Valuation

Market Cap4.78B
Enterprise Value3.47B
P/E Ratio-16.62
PEG Ratio-0.48
Price/Sales Ratio107.58
Price/Book Ratio8.29
Enterprise/Revenue92.53
Enterprise/EBITDA-16.91

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-6.45
Operating Margin-7.46

Management Effectiveness

Return On Assets-0.32
Return On Equity-0.48

Income Statement

Revenue39.42M
Revenue/Share0.14
Gross Profit14.75M
EBITDA-686.61M
Net Income-798.13M
Diluted EPS-1.44

Balance Sheet

Total Cash1.26B
Total Cash/Share2.29
Total Debt140.85M
Total Debt/Equity0.15
Current Ratio6.45
Book Value Per Share1.74

Price History

52-Week Change68.54
52-Week High25.6
52-Week Low8.91
Moving Average 50 Days16.3
Moving Average 200 Days18.82

Statistics

Average Volume1.7M
Shares Outstanding553.71M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A